This article is general information, not personal financial advice. A decision on any IPO allocation should be made with a licensed adviser.
TL;DR
Mapletree Investments, owned by Temasek, was reported in early November 2026 to be preparing an IPO early the following year at a possible valuation of S$5 billion, which would make it Singapore’s largest listing in more than a decade. Whether that revives SGX’s IPO market depends on what is actually sold. Market participants describe a split into a listed fee-earning entity and an asset-holding company, so a buyer would be underwriting a management platform’s fee streams rather than a property book. The backdrop is unforgiving: 10 listings in 2026, eight below their offer prices, and a Global Listing Board still without a confirmed IPO. MAS moves prospectus review to SGX RegCo on 4 January 2027. No offer price, yield or allocation terms have been published.
The deal on the table: a fee stream, not a property portfolio
Media reports in early November 2026 said Temasek-owned Mapletree Investments would launch an IPO early the following year at a possible valuation of S$5 billion. At that level the deal would be Singapore’s largest IPO in more than a decade. Offer details have yet to emerge.
The structure under discussion matters more than the headline number. Some market participants say the group could be split into a listed entity and an asset-holding company. The listed entity would house the fee-generating businesses across REITs, private funds, joint ventures and development assets, and would manage the asset-holding company’s assets. The asset-holding company would hold those REITs, private funds, joint ventures and property development assets directly.
Read that way, a buyer is acquiring a management platform’s fee income, not a direct stake in the buildings. That shifts what needs to be underwritten: the durability of fee streams and the growth of managed assets, rather than the mark-to-market of a property book. It also explains why the three Mapletree REITs already on SGX matter as reference points even though they are separate vehicles.
The property base is spread across markets. Singapore accounts for 24% of the portfolio, North America 22%, mainland China 15% and Hong Kong 10%, with the balance in Europe, the UK, Japan and Southeast Asia. VivoCity, Singapore’s largest shopping mall, sits among the assets.
The 2026 scorecard: 10 listings, eight below offer
Singapore’s IPO market has been busy without being rewarding. Ten listings have come to market in 2026 and eight are already trading below their offer prices, some down more than 50%.
An earlier snapshot shows the same drift. At the close on 7 August 2026, five of the nine major IPOs that year were below their offer prices and two were flat.
The pipeline has thinned as well. Blackstone-backed AirTrunk postponed a Singapore REIT listing until the following year, Thai hotel group Minor International’s Minor Food Group deferred its Singapore plans, DayOne was reported to be reassessing a US listing, and Australian data centre operator Firmus shelved its IPO.
Mapletree has pulled a listing before. It cancelled a student accommodation REIT IPO in 2022 as rates rose.
For founding families weighing an exit, the signal sits in aftermarket performance rather than subscription-day demand. Where new listings can trade more than 50% below offer, a float is a thinner exit than a trade sale unless the register is built for a long hold. A heavyweight deal that prices well and holds would do more for that calculation than any procedural reform.
The exchange itself illustrates the gap. SGX chief executive Loh Boon Chye has announced his retirement after more than 11 years, a period in which the company’s share price rose more than 150% and net profit after tax grew 112%. As an exchange it has yet to resolve the lack of momentum in local IPOs, and its revenue from derivatives, foreign exchange, data and indices means it does not depend entirely on new listings.
The rule change that shortens the runway from 4 January 2027
MAS will delegate review of prospectuses for Mainboard and Global Listing Board listings to Singapore Exchange Regulation from 4 January 2027. Until then, a company applies to SGX RegCo for a listing eligibility review and separately submits its prospectus to MAS. Under the new rules it files the listing application and prospectus together through a single electronic platform. SGX RegCo will also abolish its Listings Advisory Committee, with the aim of completing reviews within six to eight weeks.
What changes for issuers is sequence and predictability: one filing channel, one review body, a stated timeline. What does not change is demand. A faster queue does not create buyers for a deal the market does not want, and the 2026 cohort is the evidence.
The Global Listing Board is not the door this deal would use
The newly launched board is not a general fast lane. An issuer must have a market capitalisation of at least S$2 billion based on the issue price and post-invitation issued share capital. It must be primary listed on the Nasdaq Global Select Market on or before the date of admission to the Official List. The Exchange retains broad discretionary authority to deny an initial listing, apply more stringent conditions, or suspend and delist securities even where the enumerated criteria are met. Prospectuses are registered by SGX RegCo acting as an assistant of MAS.
On those terms the board is built around companies that already carry a US primary listing. A Singapore-headquartered property group’s offering would more naturally be a Mainboard exercise. The board launched without a confirmed IPO.
EQDP: S$5.4 billion already committed to the local market
MAS and the Financial Sector Development Fund announced a S$5 billion Equity Market Development Programme in February 2025. The programme aims to strengthen the local asset management and research ecosystem and increase investor interest in Singapore’s equities market. MAS invests in strategies managed by Singapore-based asset managers with a strong focus on Singapore listed equities, to broaden investor participation beyond large-cap stocks. Eligible strategies invest fully or substantially in Singapore public equities, with a preference for a higher allocation or tilt toward small- and mid-caps, must be actively managed, and should be able to draw interest and capital from other commercial investors alongside the programme’s own seeding.
By 29 September 2026, MAS had appointed a third batch of five managers under a programme it then described as S$6.5 billion, placing S$1.45 billion with them and lifting total allocation to S$5.4 billion across 14 asset managers. The first two batches were appointed in July and November 2025, with S$1.1 billion across three managers and S$2.85 billion across six. MAS also committed S$20 million from the FSDF to a GEMS market-making grant supporting SGX-listed stocks to 31 December 2028, initially covering around 80 small- and mid-cap stocks plus newly listed shares.
The programme has been credited with giving the local market a lift, and Singapore stocks were up nearly 13% for 2026 at the time of that report despite a correction. That is a supportive backdrop for a large offering rather than a substitute for one.
Mapletree’s own numbers pull in both directions
In FY2023/24, Mapletree posted a full-year net loss of S$577.2 million after asset revaluation losses, as higher interest rates pushed up property capitalisation rates. It returned to profitability the following year, and for FY2025/26 ended in March 2026 net profit rose 25.7% to S$285.6 million.
Its three listed REITs have lagged. Mapletree Pan Asia Commercial Trust was down about 20% in 2026, while Mapletree Industrial Trust and Mapletree Logistics Trust each fell about 17%, against a broader REIT market down 13%. Mainland China, Hong Kong and Japan were among the drags.
Rates remain the swing factor. Markets expected two US rate increases, in December 2026 and March 2027; oil held above US$100 a barrel; and Goldman Sachs raised its forecast for the following year’s average oil price from US$80 to US$88. A Reuters survey of more than 500 economists found 2027 inflation forecasts raised for 31 of the 50 economies covered.
No offer price, distribution yield or price-to-book multiple has been published, so a pricing comparison against the three listed REITs or against regional fund managers cannot yet be calculated. Any yield quoted for this deal before an offer document exists rests on assumptions rather than disclosure.
The CapitaLand Investment merger that faded, and the China overhang
Dow Jones reported in November 2025 that CapitaLand Investment and Mapletree were considering a merger to create one of Asia’s largest property companies, part of a series of moves involving Temasek-owned companies to assess options for reshaping portfolio businesses. Speculation has since subsided.
Observers were sceptical for reasons that still bear on a Mapletree listing. CapitaLand Investment runs an asset-light fund management model while Mapletree still carries numerous property development projects, and both hold substantial China assets. CapitaLand Investment has been recycling capital through China’s REIT market and renminbi-denominated funds, and a merger would only have increased the drag from those assets, before corporate culture and the question of who leads are counted.
What to watch before an offer document appears
Three variables decide whether this is a market-reopening deal or a one-off: the composition of the listed entity, the price discipline set against a REIT sector that fell 13% in 2026, and whether the rate cycle turns before the book opens.
Nothing published so far sets out cornerstone allocation sizes, lock-ups, or how Temasek’s ownership would be treated in the offer structure and related-party disclosures. Those terms sit in documents that have not been issued, and they matter more to a family office balance sheet than the S$5 billion headline.
Questions readers are asking
When exactly does the prospectus handover happen, and to whom?
MAS delegates review of prospectuses for Mainboard and Global Listing Board listings to SGX RegCo with effect from 4 January 2027. Filings move to a single electronic platform, the Listings Advisory Committee is abolished, and reviews are targeted at six to eight weeks.
Would a Mapletree listing use the Global Listing Board?
The board’s conditions point to issuers with a market capitalisation of at least S$2 billion and a primary listing on the Nasdaq Global Select Market on or before admission. The Exchange can still refuse or attach stricter conditions.
Has anything been officially confirmed by Mapletree or Temasek?
The reporting attributes the plan to media reports, and offer details have yet to emerge. The S$5 billion figure is a possible valuation rather than a set price.
What were the FY2023/24 and FY2025/26 results?
A net loss of S$577.2 million in FY2023/24 on asset revaluation losses, followed by net profit of S$285.6 million in FY2025/26, up 25.7%.
How did Mapletree’s listed REITs perform in 2026?
Mapletree Pan Asia Commercial Trust fell about 20%, Mapletree Industrial Trust and Mapletree Logistics Trust about 17% each, against a broader REIT market down 13%.
What documentation does a cornerstone investor need?
The public reporting does not set out allocation mechanics or documentation for cornerstone and institutional participation. The disclosure route is fixed: prospectuses are registered by SGX RegCo acting as an assistant of MAS, and from 4 January 2027 the application and prospectus are filed together on one platform. Pricing, allocation and lock-up terms would appear in offer documents that have not been published.
Where these figures come from
Figures in this article are drawn from Lianhe Zaobao, ‘Could a Mapletree listing revive SGX’s IPO market?’, published 8 November 2026; the Singapore Exchange Global Listing Board Rules and Chapter 2 Equity Securities; Monetary Authority of Singapore, ‘MAS Appoints Third Batch of EQDP Asset Managers and Commits S$20 million to Strengthen Equities Market Making Activities in Singapore’, 29 September 2026; Monetary Authority of Singapore, Equity Market Development Programme page, 21 February 2025; and The Business Times, ‘When good IPOs go bad’, 8 August 2026, used only as an August 2026 snapshot. The cohort count differs between the November 2026 report (10 listings, eight below offer) and the August 2026 snapshot (nine major IPOs, five below offer, two flat) because the two were compiled at different points in the year.